| Application no. and date | 16760801.7 (espacenet) (Federated) (European Patent Register), 20160822 | | Patent/reg. no. and date | DK/EP 3341409, 20260225 | | Publication date | 20180704 | | Priority no. and date | US 201562209000 P, 20150824, US 201562240131 P, 20151012, US 201562247906 P, 20151029, US 201562249497 P, 20151102 | | EP pub. no. and date |
EP 3341409 20180704 | | Effective date | | | Applicant/owner | GlaxoSmithKline Intellectual Property (No.2)
Limited, GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG1 2NY, GB | | Applicant ref. no. | P87743DK01 | | Inventor | Bam, Narendra B., 709 Swedeland Road
King of Prussia, PA 19406, US,
MONCK, Myrna A., 709 Swedeland Road
King of Prussia, PA 19406, US,
DALLY, Jennifer, 709 Swedeland Road
King of Prussia, PA 19406, US,
SPATARA, Michelle, 709 Swedeland Road
King of Prussia, PA 19406, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | C07K 1/16 (2006.01) , C07K 16/24 (2006.01) | | Title | BIOFARMACEUTISKE SAMMENSÆTNINGER | | Int. application no. | IB2016055012 | | Int. publication no. | WO2017033121 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
